Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Journals » Journal of Pain Management » Volume 7 Issue 4 Articles » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Fetal Alcohol Syndrome: Recognition, Differential Diagnosis and Long-Term Effects
$73.80
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Evaluation of BodyTalk, a novel mind-body medicine, for chronic pain treatment (pp. 279-290)
02.Topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: A short review (pp. 257-260)
03.Pancreatic cancer with rare leptomeningeal disease: A case report and literature review (pp. 323-327)
04.Dexamethasone preventing dural puncture headache (pp. 273-277)
05.The development of a mindfulness-based stress reduction group for adolescents with chronic pain (pp. 301-312)
Notifications more
NotificationsNotify me of updates to Dexamethasone preventing dural puncture headache (pp. 273-277)
Tell A Friend
 
Tell someone you know about this product.
Dexamethasone preventing dural puncture headache (pp. 273-277) $45.00
Authors:  Maher Fawzy Mahmoud, Hassan Mohamed Ali, Mohamed Mourad Hashim, and Ahmed Abdel Kader Fahmy
Abstract:
The usual practice of anaesthesia all over the world for caesarean section is spinal anaesthesia, which is associated with post dural puncture headache (PDPH) as a common complication, Intrathecal dexamethasone hypothetically will prevent PDPH due to its anti-inflammatory effect as it suppresses the inflammatory mediators released after the dural puncture. Methods: A double blinded randomized study of 444 females scheduled for elective Caesarean section were included in this study and allocated to three groups, D4 group (n=138) with 4 mg dexamethasone intrathecal, group D8 (n=151) with 4 mg intrathecal and a control group (n=155) injected with placebo. The three groups were monitored for incidence, severity and duration of PDPH. Results: PDPH developed in 24 cases (17.39%) in D4 group, 26 cases (17.2%) in D8 group and 51 cases (32.9%) in control group (p value >0.05), there was no significant difference in the incidence, severity or duration of PDPH between D4 and D8 groups (p>0.05). Ephedrine dose requirement in D4 (15.329.252) and in D8 (14.1115.19), while in the control group it was (27.212.125) with p value<0.01 Conclusions: intrathecal dexamethasone, either 4 mg or 8 mg decrease the PDPH, but with no statistical difference, but as a secondary result it can reduce the hypotension from the spinal anaesthesia (p<0.01). 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Dexamethasone preventing dural puncture headache (pp. 273-277)